Annual report pursuant to Section 13 and 15(d)

Stockholders Equity (Tables)

v3.21.1
Stockholders Equity (Tables)
12 Months Ended
Dec. 31, 2020
Equity [Abstract]  
Schedule of black-scholes option-pricing model

    2020     2019  
             
Underlying value of Common Stock ($)     5.59-6.44        1.7-10  
Exercise price ($)     5.59-6.44        1.7-10  
Expected volatility (%)     85.0       93.1  
Term of the option (years)     6.11       6.11  
Risk-free interest rate (%)     0.39-0.68        2.23  

Schedule of options granted to purchase ordinary shares
    For year ended
December 31, 2020
 
    Number of
Options
    Weighted
average
exercise
price
    Aggregate
intrinsic
value
 
                   
Outstanding at the beginning of period     3,143,802     $ 1.61     $ 25,733  
Granted     925,700       6.17          
Forfeited     (108,110 )     4.66          
Exercised     (391,626 )   $ 0.79          
Outstanding at the end of period     3,569,766     $ 3.12     $ 12,338  
Vested at end of period     2,334,037                  
Weighted average remaining contractual life – years as of December 31, 2020     7.62                  

 

    For year ended
December 31, 2019
 
    Number of
Options
    Weighted
average
exercise
price
    Aggregate
intrinsic
value
 
                   
Outstanding at the beginning of period     2,571,137     $ 1.34     $ 1,793  
Granted     784,329       2.03          
Forfeited     (137,083 )     1.90          
Exercised     (74,581 )     1.34          
Outstanding at the end of period     3,143,802     $ 1.61     $ 25,733  
Vested at end of period     1,482,098                  
Weighted average remaining contractual life – years as of December 31, 2019     7.88                  
Schedule of outstanding warrants
Warrant   Issuance Date   Expiration Date   Exercise
Price
Per Share
(USD)
    Number of
Shares of
Common Stock
Underlying
Warrants
 
Private Warrants issued to Yeda (see 1 below)   May 11, 2017   May 11, 2025     (* )     354,829  
Private Warrants issued to Founders (see 2 below)   November 27, 2017         -       10,589  
Private Placement Warrants (see 3 below)   IPO
(December 13, 2018)
  December 13, 2023     11.50       2,900,000  
Public Warrants (see 4 below)   IPO
(December 13, 2018)
  October 28, 2024     11.50       3,500,000  
                      6,765,418  

 

  (*) less than $0.001.
Schedule of share-based payment expenses
    Year ended
December 31,
 
    2020     2019  
             
Research and development expenses, net     1,815       450  
General and administrative     1,075       488  
      2,890       938